Order Article Reprints

Sekita T, Yamada T, Kobayashi E, Yoshida A, Hirozane T, Kawai A, Uno Y, Moriyama H, Sawa M, Nagakawa Y, et al. Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma. Cancers. 2020; 12(5):1258. https://doi.org/10.3390/cancers12051258

Sekita, Tetsuya, Tesshi Yamada, Eisuke Kobayashi, Akihiko Yoshida, Toru Hirozane, Akira Kawai, Yuko Uno, Hideki Moriyama, Masaaki Sawa, Yuichi Nagakawa, and et al. 2020. "Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma" Cancers 12, no. 5: 1258. https://doi.org/10.3390/cancers12051258

Sekita, T., Yamada, T., Kobayashi, E., Yoshida, A., Hirozane, T., Kawai, A., Uno, Y., Moriyama, H., Sawa, M., Nagakawa, Y., Tsuchida, A., Matsumoto, M., Nakamura, M., Nakayama, R., & Masuda, M. (2020). Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma. Cancers, 12(5), 1258. https://doi.org/10.3390/cancers12051258